Literature DB >> 22873430

Transparency for clinical trials--the TEST Act.

Jeffrey M Drazen.   

Abstract

Mesh：

Year:  2012        PMID： 22873430     DOI： 10.1056/NEJMe1209433

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  The project data sphere initiative: accelerating cancer research by sharing data.

Authors:  Angela K Green; Katherine E Reeder-Hayes; Robert W Corty; Ethan Basch; Mathew I Milowsky; Stacie B Dusetzina; Antonia V Bennett; William A Wood
Journal:  Oncologist       Date:  2015-04-15

2.  Use of data from registered clinical trials to identify gaps in health research and development.

Authors:  Roderik F Viergever; Robert F Terry; Ghassan Karam
Journal:  Bull World Health Organ       Date:  2013-04-03       Impact factor: 9.408

3.  [Pain measurement in animal models].

Authors:  M Busch-Dienstfertig; C Stein
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

4.  Increasing value and reducing waste: addressing inaccessible research.

Authors:  An-Wen Chan; Fujian Song; Andrew Vickers; Tom Jefferson; Kay Dickersin; Peter C Gøtzsche; Harlan M Krumholz; Davina Ghersi; H Bart van der Worp
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

5.  Against vaccine assay secrecy.

Authors:  Matthew Herder; Todd F Hatchette; Scott A Halperin; Joanne M Langley
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Methanolic extract of Tamarix Gallica attenuates hyperhomocysteinemia induced AD-like pathology and cognitive impairments in rats.

Authors:  Maibouge Tanko Mahamane Salissou; Yacoubou Abdoul Razak Mahaman; Feiqi Zhu; Fang Huang; Yuman Wang; Zhendong Xu; Dan Ke; Qun Wang; Rong Liu; Jian-Zhi Wang; Bin Zhang; Xiaochuan Wang
Journal:  Aging (Albany NY)       Date:  2018-11-12       Impact factor: 5.682

7.  Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin.

Authors:  S Swaroop Vedula; Tianjing Li; Kay Dickersin
Journal:  PLoS Med       Date:  2013-01-29       Impact factor: 11.069

8.  The quality of registration of clinical trials: still a problem.

Authors:  Roderik F Viergever; Ghassan Karam; Andreas Reis; Davina Ghersi
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

9.  Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments.

Authors:  Yacoubou Abdoul Razak Mahaman; Fang Huang; Mengjuan Wu; Yuman Wang; Zhen Wei; Jian Bao; Maibouge Tanko Mahamane Salissou; Dan Ke; Qun Wang; Rong Liu; Jian-Zhi Wang; Bin Zhang; Dan Chen; Xiaochuan Wang
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer.

Authors:  Tao Wang; Rong Lu; Sunny Lai; Joan H Schiller; Fang Liz Zhou; Bo Ci; Stacy Wang; Xiaohan Gao; Bo Yao; David E Gerber; David H Johnson; Guanghua Xiao; Yang Xie
Journal:  Cancer Inform       Date:  2019-04-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.